Pulmonary heart: definition, classification, pathogenesis, diagnostics. Morphologist’s view

Chernyaev A.L.; Dzhagatspanyan V.V.

doi:https://doi.org/10.17116/respmed2025103160

Close metadata

Recommended articles:

Quality assessment of health care delivery to patients with sexually transmitted infections in dermatovenereological institutions of Moscow according to medical records analysis. Russian Journal of Clinical Dermatology and Venereology. 2024;(5):503-509

Modern view on the etiology of gallstone disease in children. Russian Journal of Evidence-Based Gastroenterology. 2024;(4):59-68

Difficulties in lifetime diagnosis of Creutzfeldt—Jakob disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):19-27

Cognitive impairment in patients with Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):81-90

Black Acanthosis: Diagnosis and Treatment Issues. Russian Journal of Clinical Dermatology and Venereology. 2024;(6):709-712

Clinical case of auricular gouty tophi. Russian Bulletin of Otorhinolaryngology. 2024;(6):80-84

Detection of mpox virus by enzyme immunoassay in a no-instrumental format and after its inactivation with formaldehyde. Molecular Genetics, Microbiology and Virology. 2024;(4):49-53

Laboratory diagnostics of monkeypox: basic methods and prospects for new developments. Laboratory Service. 2024;(4):57-64

Obstructive sleep apnea syndrome as a predictor of atrial fibrillation. Russian Journal of Preventive Medicine. 2025;(1):109-114

Liver pathology in COVID-19. Russian Journal of Archive of Pathology. 2025;(1):53-59

Abstract:

The article is devoted to the review of literature on pulmonary hypertension (PH) and pulmonary heart (CH). CH is a change in the structure (hypertrophy and/or dilation) and function of the right ventricle (RV) of the heart, caused by a primary disorder of the respiratory system and pathology of the left sections (postinfarction cardiosclerosis, congenital and acquired heart defects), leading to PH. The classification of PH of the World Health Organization is presented, which identified 5 groups based on etiology and pathophysiology. The article considers the classification of PH, pathogenesis, clinical and pathoanatomical diagnostics. The progression of pulmonary hypertension naturally leads to the development of pulmonary hypertension, the severity of which depends on the duration of the disease and the pressure in the pulmonary artery.

Keywords:

pulmonary hypertension

pulmonary heart

pathogenesis

diagnostics

Authors:

Chernyaev A.L.

Research Institute of Pulmonology of the Federal Medical and Biological Agency of Russia

SPIN RSCI: 4433-4567
ORCID: 0000-0003-0973-9250

Dzhagatspanyan V.V.

Research Institute of Pulmonology of the Federal Medical and Biological Agency of Russia

ORCID: 0009-0002-4634-2615

Received:

25.06.2025

Accepted:

23.07.2025

Close metadata

References:

Garrison DM, Pendela VS, Memon J. Cor Pulmonale. August 8, 2023. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025.
Chuchalin AG. Pulmonary heart. Respiratory medicine. Manual, edited by A.G. Chuchalin. Published. 3rd, supplemented and revised. Volume 3. Section 4.2. Moscow: PulmoMedia LLC; 2024. (In Russ.). https://doi.org/10.18093/978-5-6048754-7-6-2024-3/562-570
Sztuka K, Orszulak-Michalak D, Jasińska-Stroschein M. Systematic review and meta-analysis of interventions tested in animal models of pulmonary hypertension. Vascul Pharmacol. 2018 Nov;110:55-63. https://doi.org/10.1016/j.vph.2018.08.004
Keramida K, Lazaros G, Nihoyannopoulos P. Right ventricular involvement in hypertrophic cardiomyopathy: Patterns and implications. Hellenic J Cardiol. 2020 Jan-Feb;61(1):3-8. https://doi.org/10.1016/j.hjc.2018.11.009
Mitra A, Ghosh RK, Bandyopadhyay D, Ghosh GC, Kalra A, Lavie CJ. Significance of Pulmonary Hypertension in Hypertrophic Cardiomyopathy. Curr Probl Cardiol. 2020 Jun;45(6):100398. https://doi.org/10.1016/j.cpcardiol.2018.10.002
Bhattacharya PT, Shams P, Ellison MB. Right Ventricular Hypertrophy. 2024 Mar 16. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025.
Humbert M, Kovacs G, Hoeper MM, Badagliacca R, Berger RMF, Brida M, Carlsen J, Coats AJS, Escribano-Subias P, Ferrari P, Ferreira DS, Ghofrani HA, Giannakoulas G, Kiely DG, Mayer E, Meszaros G, Nagavci B, Olsson KM, Pepke-Zaba J, Quint JK, Rådegran G, Simonneau G, Sitbon O, Tonia T, Toshner M, Vachiery JL, Vonk Noordegraaf A, Delcroix M, Rosenkranz S; ESC/ERS Scientific Document Group. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension Developed by the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Endorsed by the International Society for Heart and Lung Transplantation (ISHLT) and the European Reference Network on rare respiratory diseases (ERN-LUNG). Eur Heart J. 2022;43(38):3618-3731. https://doi.org/10.1093/eurheartj/ehac237
Hopkins WE. The remarkable right ventricle of patients with Eisenmenger syndrome. Coron Artery Dis. 2005;16:19-25. https://doi.org/10.1097/00019501-200502000-00004
Nath J, Foster E, Heidenreich PA. Impact of tricuspid regurgitation on long-term survival. J Am Coll Cardiol. 2004;43:405-409. https://doi.org/10.1016/j.jacc.2003.09.036
Alpert MA, Karthikeyan K, Abdullah O, Ghadban R. Obesity and Cardiac Remodeling in Adults: Mechanisms and Clinical Implications. Prog Cardiovasc Dis. 2018;61(2):114-123. https://doi.org/10.1016/j.pcad.2018.07.012
Lee DW, Gopalratnam K, Ford HJ, Rose-Jones LJ. The Value of Bedside Echocardiogram in the Setting of Acute and Chronic Pulmonary Embolism. Clin Chest Med. 2018;39(3):549-560. https://doi.org/10.1016/j.ccm.2018.04.008
Guazzi M. Pulmonary Hypertension and Heart Failure: A Dangerous Liaison. Heart Fail Clin. 2018;14(3):297-309. https://doi.org/10.1016/j.hfc.2018.02.006
Thenappan T, Ormiston ML, Ryan JJ, Archer SL. Pulmonary arterial hypertension: pathogenesis and clinical management. BMJ. 2018;14(360):j5492. https://doi.org/10.1136/bmj.j5492
Avdeev SN, Barbarash OL, Valieva ZS, Volkov AV, Veselova TN, Galyavich AS, Goncharova NS, Gorbachevsky SV, Gramovich VV, Danilov NM, Klimenko AA, Martynyuk TV, Moiseeva OM, Ryzhkova DV, Simakova MA, Sinitsyn VE, Stukalova OV, Chazova IE, Chernogrivov IE, Shmalts AA, Tsareva NA. Pulmonary hypertension, including chronic thromboembolic pulmonary hypertension. Clinical guidelines 2024. Russian journal of cardiology. 2024;29(11):170-233. (In Russ.). https://doi.org/10.15829/1560-4071-2024-6161/
Nattie EE, Bartlett D, Johnson K. Pulmonary hypertension and right ventricular hypertrophy caused by intermittent hypoxia and hypercapnia in the rat. Am Rev Respir Dis. 1978;118(4):653-658. https://doi.org/10.1164/arrd.1978.118.4.653
Yamano M, Yamano T,· Matoba S. Right ventricular dilatation: echocardiographic diferential diagnosis. Journal of Medical Ultrasonics. 2024;51:275-282. https://doi.org/10.1007/s10396-023-01399-4
Humbert M. Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: pathophysiology. Eur Respir Rev. 2010;19:59-63. https://doi.org/10.1183/09059180.00007309
Lang IM, Madani M. Update on chronic thromboembolic pulmonary hypertension. Circulation. 2014;130:508-518. https://doi.org/10.1161/CIRCULATIONAHA.114.009309
Pober JS, Min W, Bradley JR. Mechanisms of endothelial dysfunction, injury, and death. Annu Rev Pathol Mech Dis. 2009;4:71-95. https://doi.org/10.1146/annurev.pathol.4.110807.092155
Sandoo A, van Zanten JJ, Metsios GS, Carroll D, Kitas GD. The endothelium and its role in regulating vascular tone. Open Cardiovasc Med J. 2010;4:302-312. https://doi.org/10.2174/1874192401004010302
Anand V, Garg S, Duval S, Thenappan T. A systematic review and meta-analysis of trials using statins in pulmonary arterial hypertension. Pulm Circ. 2016;6(3):295-301. https://doi.org/10.1086/687304
Esipova IK. Pathological anatomy of the lungs. Moscow: Medicine; 1976. (In Russ).
Sybrecht GW. Obstructive atemwegserkrankungen: differentielle diagnostik und therapie. Therapiewoche. 1988;38(46):3387-3393.
Cuspidi C, Negri F, Giudici V, Valerio C, Meani S, Sala C, Esposito A, Masaidi M, Zanchetti A, Mancia G. Prevalence and clinical correlates of right ventricular hypertrophy in essential hypertension. J Hypertens. 2009;27(4):854-860. https://doi.org/10.1097/hjh.0b013e328324eda0
Woulfe KC, Walker LA. Physiology of the Right Ventricle Across the Lifespan. Front Physiol. 2021;12:642284. https://doi.org/10.3389/fphys.2021.642284
Witkin A, Wilcox SR, Chang Y, Huang F, Dudzinski D, Zheng H, Channick R, Kabrhel C. Impact of chronic right ventricular pressure overload in short-term outcomes of acute pulmonary embolism: A retrospective analysis. J Crit Care. 2019;51:1-5. https://doi.org/10.1016/j.jcrc.2019.01.007
Loiko IK, Gasyuk AG, Loiko VV. Functional, morphological and histochemical changes in the myocardium and their significance in the development of decompensation of pulmonary heart disease after lung resection. Archives of pathology. 1976;71(7):60-67. (In Russ).
Zamotaev IP, Vorobyeva ZV. Some issues of pathogenesis of pulmonary heart disease in chronic nonspecific lung diseases. Cardiology. 1978;7:71-75. (In Russ).
Incalzi RA, Fuso L, De Rosa M, Di Napoli A, Basso S, Pagliari G, Pistelli R. Electrocardiographic signs of chronic cor pulmonale. Circulation. 1999;99:1600-1605. https://doi.org/10.1161/01.cir.99.12.1600
Nikus K, Ricardo Pérez-Riera A, Konttila K, Barbosa-Barros R. Electrocardiographic recognition of right ventricular hypertrophy. J Electrocardiol. 2018;51(1):46-49. https://doi.org/10.1016/j.jelectrocard.2017.09.004
Calafiore AM, Bartoloni G, Al Amri H, Iacò AL, Abukhudair W, Lanzaro BI, Di Mauro M. Functional tricuspid regurgitation and the right ventricle: What we do not know is more than we know. Expert Rev Cardiovasc Ther. 2012;10(11):1351-1366. https://doi.org/10.1586/erc.12.114
Boxt LM, Katz FJ, Kolb T. Direct quantitation of right and left ventricular volumes with nuclear magnetic resonance imaging in patients with primary pulmonary hypertension. J Am Coll Cardiol.1992;19:1508-1515. https://doi.org/10.1016/0735-1097(92)90611-p
von Siebenthal C, Aubert JD, Mitsakis P, Yerly P, Prior JO, Nicod LP. Pulmonary Hypertension and Indicators of Right Ventricular Function. Front Med (Lausanne). 2016;3:23. https://doi.org/10.3389/fmed.2016.00023
Galiè N, Barberà JA, Frost AE, Ghofrani HA, Hoeper MM, McLaughlin VV, Peacock AJ, Simonneau G, Vachiery JL, Grünig E, Oudiz RJ, Vonk-Noordegraaf A, White RJ, Blair C, Gillies H, Miller KL, Harris JH, Langley J, Rubin LJ; AMBITION Investigators. Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension. N Engl J Med. 2015; 373(9):834-844. https://doi.org/10.1056/NEJMoa1413687
Ilyin GI. On the issue of diagnostics of myocardial hypertrophy by the method of separate weighing. Archives of pathology. 1956;8:97-101. (In Russ).
Fulton RM, Hutchison EC, Jones AM. Ventricular weight in cardiac hypertrophy. Br Heart J. 1952;14:413-420. https://doi.org/10.1136/hrt.14.3.413
Kryuchkova GS, Odina HM. The importance of separate weighing of the heart in assessing its hypertrophy. Archives of Pathology. 1967;1:61-65. (In Russ).
Belenkov YuN, Chazova IE. Primary pulmonary hypertension. Moscow: Knowledge Publishing House; 1999. (In Russ).